Nice, France

Jacques Greiner

This inventor holds 4 USPTO granted patents. Top assignee: Alliance Pharmaceutical Corp.. Active years: 1991-1998.


% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 108(Granted Patents)


Company Filing History:


Years Active: 1991-1998

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jacques Greiner: Innovator in Amphiphilic Phosphorus Compounds

Introduction

Jacques Greiner is a notable inventor based in Nice, France. He has made significant contributions to the field of chemistry, particularly in the development of amphiphilic phosphorus compounds. With a total of 4 patents to his name, Greiner's work has implications in various applications, including pharmaceuticals.

Latest Patents

Among his latest patents are innovative formulations of perfluoroalkylated amphiphilic phosphorus compounds. These patents detail the preparation of these compounds, which are characterized by specific formulae where V can be either O or S. Additionally, he has developed perfluorinated amphiphilic phosphorous compounds that are utilized in liposomal compositions.

Career Highlights

Greiner is currently associated with Alliance Pharmaceutical Corporation, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the understanding and application of phosphorus compounds in various scientific fields.

Collaborations

Throughout his career, Jacques Greiner has collaborated with esteemed colleagues, including Jean G. Riess and Leila Zarif. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas.

Conclusion

Jacques Greiner's contributions to the field of chemistry, particularly through his patents on amphiphilic phosphorus compounds, highlight his role as a significant inventor. His ongoing work at Alliance Pharmaceutical Corporation continues to push the boundaries of scientific research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…